"Indolizines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D007212
|
| MeSH Number(s) |
D03.633.100.496
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Indolizines".
Below are MeSH descriptors whose meaning is more specific than "Indolizines".
This graph shows the total number of publications written about "Indolizines" by people in this website by year, and whether "Indolizines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Indolizines" by people in Profiles.
-
The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication. Glycobiology. 2021 05 03; 31(4):378-384.
-
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2. Viruses. 2021 04 30; 13(5).
-
Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytother Res. 2020 Oct; 34(10):2471-2492.
-
Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors. Bioorg Med Chem. 2018 09 15; 26(17):4886-4897.
-
Structural Characterization of the Interaction of the Fibroblast Growth Factor Receptor with a Small Molecule Allosteric Inhibitor. Chemistry. 2018 Jun 04; 24(31):7861-7865.
-
Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-?B Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity. Sci Rep. 2017 06 22; 7(1):4105.
-
Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds. Eur J Med Chem. 2015 Jan 07; 89:115-27.
-
Dinaciclib for the treatment of breast cancer. Expert Opin Investig Drugs. 2014 Sep; 23(9):1305-12.
-
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity. J Med Chem. 2012 Dec 13; 55(23):10363-77.
-
Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Antiviral Res. 2010 Nov; 88(2):160-8.